Literature DB >> 2766450

Costs of treating diarrhoea in a children's hospital in Mexico City.

M Phillips, J Kumate-Rodríguez, F Mota-Hernández.   

Abstract

The treatment received by children aged under 5 years with diarrhoea was studied in the Hospital Infantil de México (Federico Goméz), Mexico City. The costs of treatment were calculated and estimates were made of how these had changed since the establishment of an oral rehydration unit in the hospital in 1985. The results indicate that drug treatment of outpatients was generally appropriate and inexpensive. In contrast, the cost of drugs for inpatients was considerably higher. The seriousness of the cases justified much of this additional expense for inpatients, but there is evidence that the costs could be reduced further without jeopardizing the quality of the care. Diagnostic tests were relatively expensive, frequently failed to identify diarrhoeal etiology, and their results correlated poorly with the treatment prescribed. The oral rehydration unit resulted in significant savings by causing a 25% fall in the number of inpatients with diarrhoea.

Entities:  

Keywords:  Americas; Antibiotics; Cost Effectiveness; Delivery Of Health Care; Developing Countries; Diarrhea; Diarrhea, Infantile; Diseases; Drugs; Economic Factors; Evaluation; Evaluation Indexes; Examinations And Diagnoses; Fees; Financial Activities; Health; Health Facilities; Hospitals; Laboratory Examinations And Diagnoses; Latin America; Mexico; North America; Oral Rehydration; Organization And Administration; Outpatient Clinic; Program Appropriateness; Program Efficiency; Program Evaluation; Programs; Quantitative Evaluation; Resource Allocation; Self Care; Treatment

Mesh:

Substances:

Year:  1989        PMID: 2766450      PMCID: PMC2491252     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

Review 1.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  Costs of diarrhoeal diseases and the savings from a control programme in Cebu, Philippines.

Authors:  B C Forsberg; E Sullesta; S Pieche; N Lambo
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

3.  Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.

Authors:  J Murray; D A McFarland; R J Waldman
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.